The chi-square test results in Table 1 indicated that although the expression level of CRABP2 was not statistically significantly associated with the metastasis status of lung cancer patients (p = 0.074), the upregulated expression trend in the metastasis group suggested that it might be involved in the biological process of tumor progression and metastasis. This evidence concerns the gene CRABP2 and neoplasm.